Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.
- DOI
- 10.1016/j.antiviral.2017.01.001
- Published
- 2017 Mar
- Container
- Antiviral research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.antiviral.2017.01.001,
title = {Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.},
author = {Khera T and Todt D and Vercauteren K and McClure CP and Verhoye L and Farhoudi A and Bhuju S and Geffers R and Baumert TF and Steinmann E and Meuleman P and Pietschmann T and Brown RJ},
year = {2017},
journal = {Antiviral research},
doi = {10.1016/j.antiviral.2017.01.001},
url = {https://doi.org/10.1016/j.antiviral.2017.01.001}
}RIS
TY - JOUR TI - Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy. AU - Khera T AU - Todt D AU - Vercauteren K AU - McClure CP AU - Verhoye L AU - Farhoudi A AU - Bhuju S AU - Geffers R AU - Baumert TF AU - Steinmann E AU - Meuleman P AU - Pietschmann T AU - Brown RJ PY - 2017 JO - Antiviral research DO - 10.1016/j.antiviral.2017.01.001 UR - https://doi.org/10.1016/j.antiviral.2017.01.001 ER -
APA
T, K., D, T., K, V., CP, M., L, V., A, F., S, B., R, G., TF, B., E, S., P, M., T, P., & RJ, B. (2017). Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy.. Antiviral research. https://doi.org/10.1016/j.antiviral.2017.01.001
Source records
- pubmed · retrieved 2026-09-26T05:30:19.841Z